THE ALZHEIMER’S DISEASE MULTIFACTORIAL THERAPEUTIC AGENT E2F4DN PREVENTS THE UPREGULATION OF THE PRO-DEATH GENE CITED 2 IN RESPONSE TO DNA DAMAGE IN NEURONS

• Aina Maria Llabrés Mas,
• Alberto Garrido García,
• Vanesa Cano Daganzo,
• Jose María Frade

Affiliations

Aina Maria Llabrés Mas

Cajal Institute, Molecular, Cellular And Developmental Neurobiology, Madrid, Spain

Alberto Garrido García

Tetraneuron, Alzheimer's Disease, Valencia, Spain

Vanesa Cano Daganzo

Tetraneuron, Alzheimer's Disease, Valencia, Spain

Jose María Frade

Cajal Institute, Molecular, Cellular And Developmental Neurobiology, Madrid, Spain